Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin‐1 expression

15 Sept 2011

Abstract excerpt

CD133 can be a marker of tumorigenic CSCs (cancer stem cells) in human GBM (glioblastoma multiforme), although tumorigenic CD133-negative CSCs have been also isolated. Additional evidence indicates that CSCs from GBM exhibit different phenotypes, with increasing interest in the potential significance of the different CSCs with respect to diagnosis, prognosis and the development of novel targets for treatment. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21916848
DOI: 10.1042/cbi20110013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin‐1 expressionPMID 21916848Read ↗

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesSemantic proximity Read ↗

Heterogeneous phenotype of human glioblastoma: in vitro study.Semantic proximity Read ↗

Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of OriginSemantic proximity Read ↗

Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?Semantic proximity Read ↗

CD133 Is Essential for Glioblastoma Stem Cell MaintenanceSemantic proximity Read ↗

Glioblastoma cancer stem cells--from concept to clinical application.Semantic proximity Read ↗

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicitySemantic proximity Read ↗

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challengesSemantic proximity Read ↗

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumorsSemantic proximity Read ↗

Characteristic features of stem cells in glioblastomas: from cellular biology to genetics.Semantic proximity Read ↗

Marker-independent Method for Isolating Slow-Dividing Cancer Stem Cells in Human GlioblastomaSemantic proximity Read ↗

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.